Getting started with Optune®

When you’re ready to start Optune, you’ll have plenty of support. Your loved ones, doctor, and the nCompass™ team at Novocure® will be there to help. Your doctor must be certified to prescribe Optune. If your doctor is not certified, they may refer you to another doctor who is certified.

To prepare for Optune, here are some steps you and your treatment team will take.

nCompass is with you every step of the way*

Getting your prescription

Your doctor

  • Writes a prescription for Optune and sends it to nCompass

Affording Optune

nCompass

  • Sends you educational materials
  • Calls your insurance provider to verify insurance and out-of-pocket costs
  • Calls you to discuss next steps

Planning treatment

Your doctor

  • Reviews your MRI & tumor location for proper array placement
  • Send this information to nCompass

Starting Optune

nCompass

  • Schedules your appointment with a Device Support Specialist (DSS)
  • DSS will show you and your caregiver how to start Optune

When you’re ready to begin treatment, nCompass will arrange for your appointment*

At your appointment, a DSS will show you how to:

  • Prepare your head (for array placement)
  • Properly place transducer arrays
  • Use Optune (start treatment)
  • Incorporate Optune into your daily life

Find out more about 24/7 support with nCompass

For more information, see the FAQs.

Optune users and caregivers discuss the Optune system and the features designed to enhance carrying comfort and usability.

Using Optune

You can receive continuous treatment with Optune almost anywhere. With your doctor’s okay, you can use Optune during your daily routine at work, while traveling, and even at social functions.

If you have newly diagnosed glioblastoma, Optune is used together with chemotherapy (after surgery and radiation with chemotherapy).

If you have recurrent glioblastoma, Optune is used alone once treatment options like surgery and radiation have been exhausted.

See what daily life with Optune is like

Sherry is an Optune user and Patient Ambassador

There are more than
1,300 certified treatment centers

in the United States

Visit Find an Optune doctor to locate one near you.

*nCompass cannot provide you with medical advice. Consult with your doctor for medical-related questions.
†Temozolomide also known as Temodar®.

What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

What is Optune Lua approved to treat?

Optune Lua is a wearable, portable, FDA-approved device indicated for the treatment of adult patients, with unresectable, locally advanced or metastatic, malignant pleural mesothelioma (MPM) to be used together with standard chemotherapy (pemetrexed and platinum-based chemotherapy).

Who should not use Optune for GBM or Optune Lua for MPM?

Optune for GBM and Optune Lua for MPM are not for everyone. Talk to your doctor if you have:

Do not use Optune for GBM or Optune Lua for MPM if you are pregnant or are planning to become pregnant. It is not known if Optune/Optune Lua is safe or effective during pregnancy.

What should I know before using Optune for GBM or Optune Lua for MPM?

Optune and Optune Lua should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure®, the maker of Optune and Optune Lua.

What are the possible side effects of Optune for GBM and Optune Lua for MPM?

The most common side effects of Optune when used together with chemotherapy for GBM (temozolomide or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, seizure, and depression.

The most common side effects when using Optune alone for GBM were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

The most common side effects of Optune Lua when used together with chemotherapy for MPM (pemetrexed and platinum-based chemotherapy) were low red blood cell count, constipation, nausea, tiredness, chest pain, fatigue, skin irritation from device use, itchy skin, and cough.

Other potential adverse effects associated with the use of Optune Lua include: treatment related skin irritation, allergic reaction to the plaster or to the gel, electrode overheating leading to pain and/or local skin burns, infections at sites of electrode contact with the skin, local warmth and tingling sensation beneath the electrodes, muscle twitching, medical device site reaction and skin breakdown/skin ulcer.

Talk to your doctor if you have any of these side effects or questions.

Caution: Federal law restricts Optune Lua to sale by or on the order of a physician. Humanitarian Device. Authorized by Federal Law for use in the treatment of adult patients with unresectable, locally advanced or metastatic, malignant pleural mesothelioma concurrently with pemetrexed and platinum-based chemotherapy. The effectiveness of this device for this use has not been demonstrated.

Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

Please click here to see the Optune Lua IFU for complete information regarding the device's indications, contraindications, warnings, and precautions.

On this site, patient and healthcare professional videos as well as all images labeled as Optune users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals. All other depictions of patients and caregivers are actor portrayals. Patient images reflect the health status of the patients at the time each photo was taken.

What is Optune approved to treat?

Optune is indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.